The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
INTERVENTIONS FOR HYPERTENSION AND STROKE
Intravenous enoxaparin anticoagulation in percutaneous left atrial cardiac procedures
EuroIntervention 2017;13:1226-1233 published online August 2017. DOI: 10.4244/EIJ-D-17-00518
Paul Guedeney1, MD; Nadjib Hammoudi1, MD, PhD; Guillaume Duthoit1, MD; Yan Yan1,2, MD; Johanne Silvain1, MD, PhD; Françoise Pousset1, MD; Richard Isnard1, MD; Alban Redheuil3, MD, PhD; Mathieu Kerneis1, MD; Jean-Philippe Collet1, MD, PhD; Gilles Montalescot1*, MD, PhD; for the ACTION Study Group
1. Sorbonne Université Paris 6, ACTION study group, Institut de Cardiologie (AP-HP), INSERM UMRS 1166, Institute of Cardiometabolism and Nutrition (ICAN), Paris, France; 2. Emergency and Critical Care Center, Beijing Anzhen Hospital, Capital Medical Unive
Aims: Percutaneous transcatheter device closure of left atrial appendage (LAA), patent foramen ovale (PFO) and atrial septal defect (ASD) are usually performed with unfractionated heparin